Epidermal growth factor receptor is essential for toll-like receptor 3 signaling

Science Signaling

Volumn 5, Issue 233, 2012, Pages

  Yamashita, Michifumi ^a   Chattopadhyay, Saurabh ^a   Fensterl, Volker ^a   Saikia, Paramananda ^a,b   Wetzel, Jaime L ^a   Sen, Ganes C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF HYDERABAD   (India)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; DOUBLE STRANDED RNA; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; TOLL LIKE RECEPTOR 3; TYROSINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE INDUCTION; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; VIRUS REPLICATION;

ANIMALS; BLOTTING, WESTERN; CELL LINE; DNA PRIMERS; ENDOSOMES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENETIC VECTORS; HUMANS; IMMUNITY, INNATE; IMMUNOPRECIPITATION; MICE; MICE, KNOCKOUT; MICROARRAY ANALYSIS; MICROSCOPY, CONFOCAL; PHOSPHORYLATION; PLASMIDS; POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TOLL-LIKE RECEPTOR 3; VIRUS DISEASES;

EID: 84864120697     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2002581     Document Type: Article

References (34)

1. C. A. Janeway Jr., R. Medzhitov, Innate immune recognition. Annu. Rev. Immunol. 20, 197-216 (2002).
2. T. Kawai, S. Akira, Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34, 637-650 (2011).
3. M. Severa, K. A. Fitzgerald, TLR-mediated activation of type I IFN during antiviral immune responses: Fighting the battle to win the war. Curr. Top. Microbiol. Immunol. 316, 167-192 (2007).
4. K. A. Cavassani, M. Ishii, H. Wen, M. A. Schaller, P. M. Lincoln, N. W. Lukacs, C. M. Hogaboam, S. L. Kunkel, TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J. Exp. Med. 205, 2609-2621 (2008).
5. E. Vercammen, J. Staal, R. Beyaert, Sensing of viral infection and activation of innate immunity by Toll-like receptor 3. Clin. Microbiol. Rev. 21, 13-25 (2008).
6. D. Iwakiri, L. Zhou, M. Samanta, M. Matsumoto, T. Ebihara, T. Seya, S. Imai, M. Fujieda, K. Kawa, K. Takada, Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3. J. Exp. Med. 206, 2091-2099 (2009).
7. M. E. Kleinman, K. Yamada, A. Takeda, V. Chandrasekaran, M. Nozaki, J. Z. Baffi, R. J. Albuquerque, S. Yamasaki, M. Itaya, Y. Pan, B. Appukuttan, D. Gibbs, Z. Yang, K. Karikó, B. K. Ambati, T. A. Wilgus, L. A. DiPietro, E. Sakurai, K. Zhang, J. R. Smith, E. W. Taylor, J. Ambati, Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 452, 591-597 (2008).
8. J. E. Cole, T. J. Navin, A. J. Cross, M. E. Goddard, L. Alexopoulou, A. T. Mitra, A. H. Davies, R. A. Flavell, M. Feldmann, C. Monaco, Unexpected protective role for Toll-like receptor 3 in the arterial wall. Proc. Natl. Acad. Sci. U.S.A. 108, 2372-2377 (2011).
9. Z. Yang, C. Stratton, P. J. Francis, M. E. Kleinman, P. L. Tan, D. Gibbs, Z. Tong, H. Chen, R. Constantine, X. Yang, Y. Chen, J. Zeng, L. Davey, X. Ma, V. S. Hau, C. Wang, J. Harmon, J. Buehler, E. Pearson, S. Patel, Y. Kaminoh, S. Watkins, L. Luo, N. A. Zabriskie, P. S. Bernstein, W. Cho, A. Schwager, D. R. Hinton, M. L. Klein, S. C. Hamon, E. Simmons, B. Yu, B. Campochiaro, J. S. Sunness, P. Campochiaro, L. Jorde, G. Parmigiani, D. J. Zack, N. Katsanis, J. Ambati, K. Zhang, Toll-like receptor 3 and geographic atrophy in age-related macular degeneration. N. Engl. J. Med. 359, 1456-1463 (2008).
10. I. B. Johnsen, T. T. Nguyen, M. Ringdal, A. M. Tryggestad, O. Bakke, E. Lien, T. Espevik, M. W. Anthonsen, Toll-like receptor 3 associates with c-Src tyrosine kinase on endosomes to initiate antiviral signaling. EMBO J. 25, 3335-3346 (2006).
11. J. N. Leonard, R. Ghirlando, J. Askins, J. K. Bell, D. H. Margulies, D. R. Davies, D. M. Segal, The TLR3 signaling complex forms by cooperative receptor dimerization. Proc. Natl. Acad. Sci. U.S.A. 105, 258-263 (2008).
12. O. de Bouteiller, E. Merck, U. A. Hasan, S. Hubac, B. Benguigui, G. Trinchieri, E. E. Bates, C. Caux, Recognition of double-stranded RNA by human toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pH. J. Biol. Chem. 280, 38133-38145 (2005).
13. M. Yamamoto, S. Sato, H. Hemmi, K. Hoshino, T. Kaisho, H. Sanjo, O. Takeuchi, M. Sugiyama, M. Okabe, K. Takeda, S. Akira, Role of adaptor TRIF in the MyD88- independent Toll-like receptor signaling pathway. Science 301, 640-643 (2003).
14. S. N. Sarkar, H. L. Smith, T. M. Rowe, G. C. Sen, Double-stranded RNA signaling by Toll-like receptor 3 requires specific tyrosine residues in its cytoplasmic domain. J. Biol. Chem. 278, 4393-4396 (2003).
15. S. N. Sarkar, K. L. Peters, C. P. Elco, S. Sakamoto, S. Pal, G. C. Sen, Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Nat. Struct. Mol. Biol. 11, 1060-1067 (2004).
16. S. N. Sarkar, C. P. Elco, K. L. Peters, S. Chattopadhyay, G. C. Sen, Two tyrosine residues of Toll-like receptor 3 trigger different steps of NF-κB activation. J. Biol. Chem. 282, 3423-3427 (2007).
17. R. Lupu, R. Colomer, G. Zugmaier, J. Sarup, M. Shepard, D. Slamon, M. E. Lippman, Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2. Science 249, 1552-1555 (1990).
18. M. Yoneyama, T. Fujita, Structural mechanism of RNA recognition by the RIG-I-like receptors. Immunity 29, 178-181 (2008).
19. Y. M. Loo, M. Gale Jr., Immune signaling by RIG-I-like receptors. Immunity 34, 680-692 (2011).
20. P. Nakhaei, P. Genin, A. Civas, J. Hiscott, RIG-I-like receptors: Sensing and responding to RNA virus infection. Semin. Immunol. 21, 215-222 (2009).
21. M. J. Servant, N. Grandvaux, B. R. tenOever, D. Duguay, R. Lin, J. Hiscott, Identification of the minimal phosphoacceptor site required for in vivo activation of interferon regulatory factor 3 in response to virus and double-stranded RNA. J. Biol. Chem. 278, 9441-9447 (2003).
22. M. Mori, M. Yoneyama, T. Ito, K. Takahashi, F. Inagaki, T. Fujita, Identification of Ser- 386 of interferon regulatory factor 3 as critical target for inducible phosphorylation that determines activation. J. Biol. Chem. 279, 9698-9702 (2004).
23. A. Sorkin, L. K. Goh, Endocytosis and intracellular trafficking of ErbBs. Exp. Cell Res. 314, 3093-3106 (2008).
24. P. D. Stahl, M. A. Barbieri, Multivesicular bodies and multivesicular endosomes: The "ins and outs " of endosomal traffic. Sci. STKE 2002, pe32 (2002).
25. H. Hanafusa, K. Ishikawa, S. Kedashiro, T. Saigo, S. Iemura, T. Natsume, M. Komada, H. Shibuya, A. Nara, K. Matsumoto, Leucine-rich repeat kinase LRRK1 regulates endosomal trafficking of the EGF receptor. Nat. Commun. 2, 158 (2011).
26. L. Coussens, T. L. Yang-Feng, Y. C. Liao, E. Chen, A. Gray, J. McGrath, P. H. Seeburg, T. A. Libermann, J. Schlessinger, U. Francke, A. Levinson, A. Ullrich, Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230, 1132-1139 (1985).
27. H. Häcker, V. Redecke, B. Blagoev, I. Kratchmarova, L. C. Hsu, G. G. Wang, M. P. Kamps, E. Raz, H. Wagner, G. Häcker, M. Mann, M. Karin, Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439, 204-207 (2006).
28. M. P. Kamps, S. S. Taylor, B. M. Sefton, Direct evidence that oncogenic tyrosine kinases and cyclic AMP-dependent protein kinase have homologous ATP-binding sites. Nature 310, 589-592 (1984).
29. J. E. Murphy, B. E. Padilla, B. Hasdemir, G. S. Cottrell, N. W. Bunnett, Endosomes: A legitimate platform for the signaling train. Proc. Natl. Acad. Sci. U.S.A. 106, 17615-17622 (2009).
30. J. R. Woodburn, The epidermal growth factor receptor and its inhibition in cancer therapy. Pharmacol. Ther. 82, 241-250 (1999).
31. M. P. Kamps, B. M. Sefton, Neither arginine nor histidine can carry out the function of lysine-295 in the ATP-binding site of p60src. Mol. Cell. Biol. 6, 751- 757 (1986).
32. G. Waksman, S. E. Shoelson, N. Pant, D. Cowburn, J. Kuriyan, Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: Crystal structures of the complexed and peptide-free forms. Cell 72, 779-790 (1993).
33. P. Sheffield, S. Garrard, Z. Derewenda, Overcoming expression and purification problems of RhoGDI using a family of "parallel" expression vectors. Protein Expr. Purif. 15, 34-39 (1999).
34. F. Terenzi, P. Saikia, G. C. Sen, Interferon-inducible protein, P56, inhibits HPV DNA replication by binding to the viral protein E1. EMBO J. 27, 3311-3321 (2008).